Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Burkitt Lymphoma 7Meningeal Carcinomatosis 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 4Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Meningeal Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Uveal Melanoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Nevus 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Monocytic, Acute 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1Hematopoietic and Lymphatic System Neoplasm 1Germinoma 1Down Syndrome 1Diabetes Insipidus 1Brain Neoplasms 1

Interventions

Cyclophosphamide 7Biopsy 6fludarabine 5Specimen Handling 5Magnetic Resonance Spectroscopy 5ruxolitinib 3X-Rays 3Whole-Body Irradiation 3Vincristine 3Peripheral Blood Stem Cell Transplantation 3Cytarabine 310-propargyl-10-deazaaminopterin 3sodium-iodide symporter 2pembrolizumab 2cemiplimab 2Photons 2Methotrexate 2Ipilimumab 2Immunoglobulin G 2Hydrocortisone 2Etoposide 2Disulfides 2Dexamethasone 2Calcium Dobesilate 2CTLA-4 Antigen 2Azacitidine 2venetoclax 1tagraxofusp 1romidepsin 1nelarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, T-Cell × Spinal Puncture × Clear all
NCT07225985 2026-05-11

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
50 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡